共 50 条
Effects of Phase III Cardiac Rehabilitation on Mortality and Cardiovascular Events in Elderly Patients With Stable Coronary Artery Disease
被引:19
|作者:
Onishi, Tomo
[1
,3
]
Shimada, Kazunori
[1
,3
]
Sato, Hiroyuki
[2
,3
]
Seki, Eriko
[1
]
Watanabe, Yoshiro
[1
]
Sunayama, Satoshi
[1
]
Ohmura, Hirotoshi
[1
]
Masaki, Yoshiyuki
[1
]
Nishitani, Miho
[1
]
Fukao, Kosuke
[1
]
Kume, Atsumi
[1
]
Sumide, Takahiro
[3
]
Mokuno, Hiroshi
[1
]
Naito, Hisashi
[3
,4
]
Kawai, Sachio
[1
,4
]
Daida, Hiroyuki
[1
]
机构:
[1] Juntendo Univ, Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138421, Japan
[2] Juntendo Univ, Sch Med, Dept Gen Med, Tokyo 1138421, Japan
[3] Juntendo Univ Hosp, Juntendo Sports Clin, Tokyo, Japan
[4] Juntendo Univ, Sch Hlth & Sports Sci, Dept Sports Sci, Chiba, Japan
基金:
日本学术振兴会;
关键词:
Cardiovascular events;
Cardiac rehabilitation;
Coronary artery disease;
Elderly patients;
Prognosis;
QUALITY-OF-LIFE;
ACUTE MYOCARDIAL-INFARCTION;
RANDOMIZED CLINICAL-TRIAL;
PROGRAM J-CARP;
RISK-FACTORS;
EXERCISE CAPACITY;
BEHAVIORAL-CHARACTERISTICS;
HEART-DISEASE;
FOLLOW-UP;
JAPAN;
D O I:
10.1253/circj.CJ-09-0638
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Background: Cardiac rehabilitation (CR) has numerous benefits, including reduction of mortality and cardiovascular events, in patients with coronary artery disease (CAD). However, the long-term effect of phase III CR in elderly patients with stable CAD is still unknown. Methods and Results: The 111 elderly male CAD patients (65 years), including 37 subjects participating in supervised CR for 6 months and 74 age-matched controls, were analyzed. The patients were followed for up to 3,500 days, until the occurrence of death or 1 of the following major adverse cardiovascular events (MACE): cardiovascular death, acute coronary syndrome, refractory angina requiring revascularization, admission for congestive heart failure, or stroke. All-cause mortality tended to be lower in the CR group than in the Control group (14% vs 28%, P=0.081). The MACE incidence was significantly lower in the CR group than in the Control group (30% vs 62%, P=0.001). Multivariate Cox proportional hazard analysis showed that the MACE incidence was significantly lower in the CR group than in the Control group [adjusted hazard ratio 0.43 (95% confidence interval 0.20-0.91), P=0.027]. Conclusions: Phase III CR has the beneficial effect of reducing cardiovascular events even in elderly patients with stable CAD. (Circ J 2010; 74: 709-714)
引用
收藏
页码:709 / 714
页数:6
相关论文